Legato Capital Management »

Keros Therapeutics shares owned by Legato Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $346k 17k 20.36

More positions owned by Legato Capital Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Argan (AGX)
Ies Hldgs (IESC)
Alphabet Inc Class A cs (GOOGL)
Stonex Group (SNEX)
Microsoft Corporation (MSFT)
VSE Corporation (VSEC)
Amazon (AMZN)
Agilysys (AGYS)
Triumph Ban (TFIN)
Kratos Defense & Security Solutions (KTOS)
ePlus (PLUS)
UFP Technologies (UFPT)

View all positions for Legato Capital Management

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics